| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Csto | Chief Technical Officer
1 company
Flanagan W. Michael is a Chief Scientific Officer at Avidity Biosciences, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2024 | RNA Avidity Biosciences, Inc. | Csto | Sale+OE | 111,394 | $40.40 | $4,500,244.20 | -34.4% | |
| Jun 18, 2024 | RNA Avidity Biosciences, Inc. | Csto | Sell | 10,106 | $39.13 | $395,444.75 | -16.6% | |
| Jan 22, 2024 | RNA Avidity Biosciences, Inc. | Csto | Sell | 4,129 | $10.13 | $41,826.77 | -10.3% |